GM Advisory Group’s Qiagen QGEN Stock Holding History

GM Advisory Group’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$380K	Sell	9,500 -500	-5%	-$23.7K	0.01%	271
2025 Q4	$450K	Hold	10,000	–	–	0.02%	229
2025 Q3	$443K	Hold	10,000	–	–	0.02%	201
2025 Q2	$480K	Buy	+10,000	New	+$435K	0.02%	200

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

GM Advisory Group's QGEN Position: Q1 2026 in Review

GM Advisory Group reduced its Qiagen (QGEN) stake by 5% in Q1 2026, selling an estimated $23.7K and leaving 9,500 shares worth $380K. The position accounts for 0.01% of the portfolio, ranked #271.

GM Advisory Group first reported a position in QGEN in Q2 2025 and has held it in 4 quarters since. The position peaked at $480K in Q2 2025. 346 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

GM Advisory Group held 9,500 shares of Qiagen worth $380K as of Q1 2026.
GM Advisory Group sold 500 Qiagen shares in Q1 2026, an estimated $23.7K.
Qiagen made up 0.01% of GM Advisory Group's portfolio in Q1 2026, its #271 holding.
GM Advisory Group first reported a position in Qiagen in Q2 2025 and has held it in 4 quarters since.
GM Advisory Group's Qiagen position peaked at $480K in Q2 2025.
346 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on GM Advisory Group's 13F filing for Q1 2026, filed 28 Apr 2026.